Jointly provided by the Potomac Center for Medical Education and Rockpointe
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Guidelines for idiopathic pulmonary fibrosis (IPF) management were created in 2011 and updated in 2015 by a Joint Committee of the American Thoracic Society (ATS) and European, Japanese, and Latin American societies; however, wide variability remains in the management of IPF. Many clinicians have difficulty developing and implementing cross-functional multidisciplinary team initiatives and enhancing communication among health care providers. In order to improve health outcomes for patients with IPF, this program will review proven IPF diagnosis and management strategies to enable pulmonary units to perform a critical assessment of current practices and identify barriers to optimal outcomes, following examples from the Pulmonary Fibrosis Foundation (PFF) and the recently established PFF Care Center Network.
This activity is intended for pulmonologists, allergists, immunologists, hospitalists, respiratory therapists, rheumatologist, internists, radiologists, pathologists, NPs, PAs, nurses, and other health professionals who are part of the multidisciplinary care team for patients with IPF.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
Identify patients presenting with signs and risk factors of IPF and refer for HRCT to confirm diagnosis earlier in disease progression
Incorporate the most recent guidelines to develop an individualized management plan for each IPF patient, considering comorbidities, preferences, needs, and resources
Describe strategies to facilitate a multidisciplinary care team approach, including shared decision-making through provider-patient communication on symptom control, side-effect management, and therapy adherence
There is no fee for this activity.
Conflict Of Interest Disclosure Policy
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Steven Nathan, MD Medical Director Advanced Lung Disease & Transplant Program Inova Fairfax Hospital Professor of Medicine, Virginia Commonwealth University-Inova Fairfax campus Falls Church, VA
Dr. Nathan discloses the following: Consultant/Independent Contractor: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals Grant/Research: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals Honoraria: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals Speaker's Bureau: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals
Leann L. Silhan, MD Assistant Professor Division Director of Education Division of Pulmonary and Critical Care Medicine Department of Medicine Johns Hopkins University School of Medicine Baltimore, MD
Dr. Silhan discloses the following: Consultant/Independent Contractor: Boehringer Ingelheim
Accredited Provider Disclosure
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Jeanelle Spencer, PhD, Carole Drexel, PhD, CHCP, Blair St. Amand, Jay Katz, MA, CHCP, and Ashley Marostica, RN, MSN, have nothing to disclose.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.00 AMA PRA Category I CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.